Stay ConnectedTalking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering.
Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050.
Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
Copyright: © 2023 Colabra
Dr. Ray Shillito is a scientist that spent the early part of his career in plant transformation, attempting novel approaches in the early 1980’s. It was a time of rapid development of new techniques, and a race to move genes into plants with the goal of genetic improvement. Dr. Shillito shares his memories of that time, and then touches on his recent passion– how to train scientists to prepare better presentations. In the second part of the podcast I speak with Angie Adkin. Angie is a graduate student that hosts the All Creatures Podcast, and we discuss the value of creating new media and the associated career benefits and pitfalls.
Follow Dr. Ray Shillito on Twitter: @Shillito_Ray
Follow All Creatures Podcast on Twitter: @allcreaturespod
All Creatures Podcast on Facebook
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
In 2017 we recorded 53 new episodes, including guest hosts and a great range of outstanding guests. 2018 has some interesting new edges. Kevin and Paul talk about the year in review, and the plans for the future.
End of 2017 with 672,000+ downloads. Thank you for listening and for all of your support.
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Groundnut, or peanut, is a major food staple and excellent protein source in many parts of the world. However, since the nut itself develops in soil, it is prone to fungal infection with Aspergillus flavus, the species that produces aflatoxin. Aflatoxins are some of the most potent naturally-produced carcinogens and are thought to be responsible for liver cancer worldwide. In the Developing World fungal infection and toxin production are a problem on fresh and stored food products. Fungicides and other chemical controls are not readily available. Dr. Dilip Shah from the Donald Danforth Plant Science Center worked with a team of researchers to devise a multi-faceted plan to protect groundnut from fungal infections. In this week’s podcast he describes two approaches, of how genetic engineering can be used to control the fungus, or its production of the toxin.
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Nikolai Vavilov was a Russian scientist in the early 1900’s. He was known for his characterization of plants, understanding crop domestication, and the centers of origin for many species. He traveled the world with expedition parties to identify and characterize plant species. His collections of seed and samples were extensive, and he was noted as one of the great scientists of the time, and understood inheritance while scientists were developing the concept of a gene. However, as Stalin rose to power Vavilov’s work was less appreciated. His Darwinian concepts were inconsistent with the interests of the government doctrine, which would ultimately lead to his imprisonment and slow execution. The story is told by Dr. Jules Janick, Distinguished Professor at Purdue University.
In the second half of the podcast I speak with Natalie Newell, Director and Producer of the Science Moms documentary. The film provides interviews with five different mothers that are forced to navigate a maze of parenting misinformation available on the internet. They also are scientists or science communicators, providing unique insights and analysis of moms tired of attempts of shaming and manipulation, driven by unscrupulous marketers and activists. We also address the claims that it was “all paid for and developed by an agrotech PR firm.
Watch the Science Moms trailer
Science Moms website
Follow Natalie Newell on Twitter; @ncnewell
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Podcast 112 was a discussion of the dicamba situation. Since that episode was recorded I attended a conference from the North Central Weed Science Society in St. Louis, and heard more information first hand. I also gave my perspectives in a 20 minute talk. In today’s podcast bonus track I recap some of the discussion. Bottom line, this problem needs to be solved, and the companies that sell the seeds and chemicals better stop pointing fingers. They need to make harmed farmers whole again and fix the technology before suggesting its continued use.
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Over the last two years we have heard reports of herbicide damage to Midwestern crops, bearing the signatures of damage from dicamba. Dicamba is an older herbicide, an auxin analog that mimics a plant hormone associated with growth and cell division. This herbicide was made relevant again in soybeans and cotton, which have been genetically engineered to be dicamba resistant, needed because of the increase in glyphosate-resistant weeds. Since the deployment of these seeds, farmers have seen evidence of herbicide damage, opening endless finger pointing and legal gyrations. University extension experts have weighed in. Companies deny wrongdoing. How to sort this out? This episode features guest Karen Corrigan, an independent agronomist that provides boots-on-the-ground assessment of the problem, how it happens, and what is likely to occur in the next steps.
Follow Karen on Twitter: @weedgirl24
Also listen to Karen on Girls Talk Ag podcast!
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Over the last century there was an incredible rise in the number of seed companies, driven primarily by the profitability of hybrid seeds in regional markets. After the 1980’s, there has been great consolidation in the seed markets, resulting in about a dozen companies selling the vast majority of seeds. The field is dominated by the “Big Six”, several companies that had broad portfolios, that purchased smaller companies in the last decades’ consolidations. The consolidation continues, as large companies are buying each other, concentrating technology and resources in a few corporate hands. Prof. Sylvie Bonny from INRA discusses the concerns and impacts of consolidation, as presented in her recent review in Sustainability.
Download the paper discussed here.
Follow Dr. Vincelli: @pvincell
His blog: Out-of-the-box
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
The promises of gene therapy have been slow to reach the public for many reasons. Technologies conceived in the 1980’s had a substantial regulatory and proof-of-concept road ahead of them, leading to slow development and deployment. One of the major issues is that these therapies were designed for humans, where ethics concerns and regulation are a challenge to navigate. However, it is possible to demonstrate efficacy in animals. Emily Mullin is the Associate Editor at MIT Technology Review. She recently covered the application of gene therapy to animals, and now describes its application in veterinary capacities where regulation is much lower than in human therapy.
Follow Emily on Twitter: @emilylmullin
Read her work at MIT Technology Review
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
In this week’s podcast Dr. Jonnny Dalzell guest hosts from Tanzania. He visits with scientists from IITA that are helping devise solutions to nematodes. Nematodes are microscopic soil worms that are difficult to control and require substantial chemical inputs that are not always available and can be hazardous. Uncontrolled nematodes lead to damaged crops, and damage is not always apparent until it is too late. Dr. Dalzell speaks to IITA Kenya scientists Dr. Nessie Luambano, Dr. Danny Coyne, and Dr. Leena Tripathi. They discuss the problem of nematodes, some of the proposed solutions, and some of the frustrations of having good work stalled because of a lack of funding and political will to move them forward.
Follow Dr. Dalzell: @jjdalzell
His website: https://johnathandalzell.com/
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Gene editing has been the center of attention, affecting everything from plants, to mushrooms, to livestock, to human medicine. However, when we discuss gene editing we typically describe the CRISPR Cas9 system. Such tools have grabbed recent limelight. But churning in the background, the other gene editing methods have been making progress for for years, and products are moving rapidly through pipelines toward approval. Such products will soon be available from Calyxt Corporation. Calyxt Chief Science Officer Dr. Dan Voytas discusses how TALEN, a custom sequence-specific nuclease, functions in gene editing. He contrasts it with the Cas9 system and then describes the company pipeline, with products soon to be on the market. He also discusses regulation of the products derived from TALEN technology.
Calyxt Corporation website and pipeline here.
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Our TOPPODCAST Picks 
